Defining cancer-risk, and assessing diagnostic usefulness of myositis serology, in dermatomyositis- Part 2

由 Madan, V, Chinoy, H, Griffiths, C E M, Cooper, R G
發表在 Clin Exp Dermatol (2009)

Academic training in rheumatology in 2009: a UK trainee survey

由 Gompels, LL, Chinoy, H, Devakumar, V, Bax, D, Mackworth-Young, CG
發表在 Clin Med (Lond) (2011)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis

由 Gunawardena, H, Wedderburn, LR, Betteridge, ZE, Chinoy, H, North, J, Cooper, RG, Ramanan, AV, Davidson, JE, McHugh, NJ
出版 2008

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease

由 Al‐Janabi, A., Littlewood, Z., Griffiths, C.E.M., Hunter, H.J.A., Chinoy, H., Moriarty, C., Yiu, Z.Z.N., Warren, R.B.
發表在 Br J Dermatol (2021)

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis

由 Gunawardena, H, Wedderburn, L R, Chinoy, H, Betteridge, Z E, North, J, Ollier, W E R, Cooper, R G, Oddis, C V, Ramanan, A V, Davidson, J E, McHugh, N J
出版 2009

The PTPN22 gene is associated with juvenile and adult UK Caucasian idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype

由 Chinoy, H., Platt, H., Lamb, J.A., Betteridge, Z., Gunawardena, H., Fertig, N., Varsani, H., Davidson, J., Oddis, C.V., McHugh, N.J., Wedderburn, L.R., Ollier, W.E.R., Cooper, R.G.
發表在 Arthritis Rheum (2008)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

由 Betteridge, Z., Tansley, S., Shaddick, G., Chinoy, H., Cooper, R.G., New, R.P., Lilleker, J.B., Vencovsky, J., Chazarain, L., Danko, K., Nagy-Vincze, M., Bodoki, L., Dastmalchi, M., Ekholm, L., Lundberg, I.E., McHugh, N.
發表在 J Autoimmun (2019)

Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

由 Chinoy, H, Adimulam, S, Marriage, F, New, P, Vincze, M, Zilahi, E, Kapitány, A, Gyetvai, A, Ekholm, L, Novota, P, Remakova, M, Charles, P, McHugh, N J, Padyukov, L, Alfredsson, L, Vencovsky, J, Lundberg, I E, Danko, K, Ollier, W E, Cooper, R G
出版 2011

Phenotype Standardization for Statin-Induced Myotoxicity

由 Alfirevic, A, Neely, D, Armitage, J, Chinoy, H, Cooper, R G, Laaksonen, R, Carr, D F, Bloch, K M, Fahy, J, Hanson, A, Yue, Q-Y, Wadelius, M, Maitland-van Der Zee, A H, Voora, D, Psaty, B M, Palmer, C N A, Pirmohamed, M
出版 2014

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies

由 Jani, M, Massey, J, Wedderburn, L R, Vencovský, J, Danko, K, Lundberg, I E, Padyukov, L, Selva-O’Callaghan, A, Radstake, T, Platt, H, Warren, R B, Griffiths, C E, Lee, A, Gregersen, P K, Miller, F W, Ollier, W E, Cooper, R G, Chinoy, H, Lamb, J A
發表在 Ann Rheum Dis (2014)

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

由 Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H, van Engelen, B G M
發表在 Ann Rheum Dis (2017)